LNSMGQD
LNSMGQD is a peptide that targets the adhesion interface of desmoglein DSG1 and DSG3, and interferes with the DSG trans-interaction single peptide (SP) component. LNSMGQD blocks autoantibody-induced loss of DSG trans-interactions by binding to DSGs, inhibiting p38 MAPK activation and keratin filament retraction. LNSMGQD can be used to study autoimmune skin diseases such as pemphigus vulgaris[1].
Product Specifications
CAS Number
1152066-26-6
UNSPSC
12352209
Target
P38 MAPK
Related Pathways
MAPK/ERK Pathway
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Purity
99.92
Smiles
O=C(N[C@@H](CC(N)=O)C(N[C@@H](CO)C(N[C@@H](CCSC)C(NCC(N[C@@H](CCC(N)=O)C(N[C@@H](CC(O)=O)C(O)=O)=O)=O)=O)=O)=O)[C@H](CC(C)C)N
Molecular Formula
C29H49N9O13S
Molecular Weight
763.82
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD45 / LCA (B-Cell Marker) (rPTPRC/1460), 0.2mg/mL
Human Kappa Light Chain / IGKC (B-Cell Marker) (rKLC709), CF405S conjugate, 0.1mg/mL
Human IgG Immunoglobulin (B33/20), CF640R conjugate, 0.1mg/mL
Von Willebrand Factor (3E2D10 + VWF635), Biotin conjugate, 0.1mg/mL
